ES8403522A1 - "procedimiento para la produccion simultanea de los productos geneticos de dos o mas genes afines" - Google Patents

"procedimiento para la produccion simultanea de los productos geneticos de dos o mas genes afines"

Info

Publication number
ES8403522A1
ES8403522A1 ES522762A ES522762A ES8403522A1 ES 8403522 A1 ES8403522 A1 ES 8403522A1 ES 522762 A ES522762 A ES 522762A ES 522762 A ES522762 A ES 522762A ES 8403522 A1 ES8403522 A1 ES 8403522A1
Authority
ES
Spain
Prior art keywords
interferon
arg
genetic information
production
dna sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES522762A
Other languages
English (en)
Spanish (es)
Other versions
ES522762A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6164725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8403522(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES522762A0 publication Critical patent/ES522762A0/es
Publication of ES8403522A1 publication Critical patent/ES8403522A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/142—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES522762A 1982-05-28 1983-05-27 "procedimiento para la produccion simultanea de los productos geneticos de dos o mas genes afines" Expired ES8403522A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823220116 DE3220116A1 (de) 1982-05-28 1982-05-28 Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ES522762A0 ES522762A0 (es) 1984-03-16
ES8403522A1 true ES8403522A1 (es) 1984-03-16

Family

ID=6164725

Family Applications (2)

Application Number Title Priority Date Filing Date
ES522762A Expired ES8403522A1 (es) 1982-05-28 1983-05-27 "procedimiento para la produccion simultanea de los productos geneticos de dos o mas genes afines"
ES529360A Expired ES8500321A1 (es) 1982-05-28 1984-02-01 Procedimiento para producir un microorganismo

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES529360A Expired ES8500321A1 (es) 1982-05-28 1984-02-01 Procedimiento para producir un microorganismo

Country Status (22)

Country Link
US (1) US4820638A (https=)
EP (1) EP0095702B1 (https=)
JP (2) JPH0774238B2 (https=)
KR (1) KR920006349B1 (https=)
AT (1) ATE42114T1 (https=)
AU (1) AU565479B2 (https=)
DD (1) DD211359C4 (https=)
DE (2) DE3220116A1 (https=)
DK (1) DK164742C (https=)
ES (2) ES8403522A1 (https=)
FI (1) FI82072C (https=)
GR (1) GR79236B (https=)
HK (1) HK112893A (https=)
HU (1) HU196452B (https=)
IL (1) IL68790A (https=)
MX (1) MX9202815A (https=)
NO (1) NO168538C (https=)
NZ (1) NZ204384A (https=)
SG (1) SG38692G (https=)
SU (1) SU1346048A3 (https=)
UA (1) UA8037A1 (https=)
ZA (1) ZA833845B (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
US4709324A (en) * 1985-11-27 1987-11-24 Motorola, Inc. Data processor control unit having an interrupt service using instruction prefetch redirection
CA2025180A1 (en) * 1989-10-12 1991-04-13 William G. Weisburg Nucleic acid probes and methods for detecting pathogenic candida yeasts
US6685933B1 (en) 1998-07-28 2004-02-03 The United States Of America As Represented By The Department Of Health And Human Services Interferon α hybrids
AU2587002A (en) * 2000-11-03 2002-05-15 Biomedicines Inc Method for short-term and long-term drug dosimetry
FR2817559B1 (fr) * 2000-12-06 2003-12-12 Genodyssee Procede de determination d'un ou plusieurs polymorphisme(s) fontionnel(s) dans la sequence nucleique d'un gene "candidat" fonctionnel preselectionne et ses applications
FR2821625B1 (fr) * 2001-03-01 2003-05-16 Genodyssee Nouveaux polynucleotides comportant un polymorphisme de type snp fonctionnel dans la sequence nucleotidique du gene ifn-alpha-2 ainsi que de nouveaux polypeptides codes par ces polynucleotides et leurs utilisations therapeutiques
FR2823220B1 (fr) * 2001-04-04 2003-12-12 Genodyssee Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
IL161889A0 (en) * 2001-11-09 2005-11-20 Biomedicines Inc Method for treating diseases with omega interferon
US20040063912A1 (en) * 2002-03-15 2004-04-01 The Brigham And Women's Hospital, Inc. Central airway administration for systemic delivery of therapeutics
WO2003099320A1 (en) 2002-05-24 2003-12-04 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
DE60332358D1 (de) * 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
EP2327724A3 (en) 2004-02-02 2011-07-27 Ambrx, Inc. Modified human growth hormone polypeptides and their uses
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
MX2008014870A (es) 2006-05-30 2009-02-12 Intarcia Therapeutics Inc Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
EP2049081B1 (en) 2006-08-09 2012-11-14 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
US20080260820A1 (en) * 2007-04-19 2008-10-23 Gilles Borrelly Oral dosage formulations of protease-resistant polypeptides
HRP20130259T1 (hr) 2007-04-23 2013-04-30 Intarcia Therapeutics, Inc. Suspenzijske formulacije inzulinotropnih peptida i njihove uporabe
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
SMT201700583T1 (it) 2009-09-28 2018-01-11 Intarcia Therapeutics Inc Instaurazione e/o terminazione rapida di erogazione di farmaci in modo sostanzialmente stazionario
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
WO2013024158A1 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of protein kinase inhibitors and interferons or of protein kinase inhibitors and direct acting antivirals for the treatment and the prevention of hcv infection
WO2013024156A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
WO2014033266A1 (en) 2012-08-31 2014-03-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Anti-sr-bi antibodies for the inhibition of hepatitis c virus infection
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
RU2760007C2 (ru) 2016-05-16 2021-11-22 Интарсия Терапьютикс, Инк. Полипептиды, селективные к рецепторам глюкагона, и способы их применения
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2906160A1 (de) * 1979-02-17 1980-09-04 Thomae Gmbh Dr K Verbessertes verfahren zur herstellung von humaninterferon
AU538665B2 (en) * 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
IE54096B1 (en) * 1980-01-08 1989-06-21 Biogen Nv Dn sequences, recombinant dna molecules and processes for producing human interferon - like polypeptides
US4530901A (en) * 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
GB2068970B (en) * 1980-02-06 1983-06-22 Searle & Co Recombinant dna technique for the preparation of a protein resembling human interferon
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
ES8302778A1 (es) * 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
DE3106982A1 (de) * 1981-02-25 1982-09-09 Dr. Karl Thomae Gmbh, 7950 Biberach "neues tridecadeoxynukleotid, verfahren zu seiner herstellung und verwendung"
IL63327A (en) * 1981-07-16 1985-11-29 Yeda Res & Dev Production of interferon beta1 and alpha-phage recombinants for its production in host bacteria
GB2108510B (en) * 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof

Also Published As

Publication number Publication date
FI831818A0 (fi) 1983-05-23
DK164742C (da) 1992-12-28
ES529360A0 (es) 1984-10-01
DD211359A5 (de) 1984-07-11
NO831903L (no) 1983-11-29
FI831818L (fi) 1983-11-29
ES522762A0 (es) 1984-03-16
NZ204384A (en) 1986-11-12
GR79236B (https=) 1984-10-22
IL68790A (en) 1991-06-10
DE3379591D1 (en) 1989-05-18
EP0095702A1 (de) 1983-12-07
NO168538B (no) 1991-11-25
ATE42114T1 (de) 1989-04-15
JPS5925689A (ja) 1984-02-09
IL68790A0 (en) 1983-09-30
DK239383D0 (da) 1983-05-27
HU196452B (en) 1988-11-28
AU565479B2 (en) 1987-09-17
DD211359C4 (de) 1986-09-24
HK112893A (en) 1993-10-29
EP0095702B1 (de) 1989-04-12
FI82072C (fi) 1991-01-10
KR840004944A (ko) 1984-10-31
NO168538C (no) 1992-03-04
DE3220116C2 (https=) 1993-02-18
SG38692G (en) 1992-09-04
ES8500321A1 (es) 1984-10-01
KR920006349B1 (ko) 1992-08-03
ZA833845B (en) 1985-01-30
UA8037A1 (uk) 1995-12-26
JPH0678774A (ja) 1994-03-22
JP2558422B2 (ja) 1996-11-27
MX9202815A (es) 1992-06-30
JPH0774238B2 (ja) 1995-08-09
DE3220116A1 (de) 1983-12-01
DK239383A (da) 1983-11-29
FI82072B (fi) 1990-09-28
DK164742B (da) 1992-08-10
AU1504483A (en) 1983-12-01
US4820638A (en) 1989-04-11
SU1346048A3 (ru) 1987-10-15

Similar Documents

Publication Publication Date Title
ES8403522A1 (es) "procedimiento para la produccion simultanea de los productos geneticos de dos o mas genes afines"
ZA942720B (en) Isolation, selection and propagation of animal stem cells; genetically modified animals and animal cells, and constructs for their production
ATE173765T1 (de) Binäres cryptocytotoxisches verfahren zur herstellung von hybrid-saatgut
UA40661C2 (uk) Вектор для введення бажаного гена у рослину (варіанти), спосіб одержання трансгенної рослини, спосіб введення, принаймні, двох бажаних генів у рослину
BR8200191A (pt) Celula viva renina preprorrenina prorrenina processo para obter expressao de preporrenina prorrenina e renina gene de prorrenina preprorrenina e renina e coli material dna recombinador saccharomyces cerevisiae polipetidio processo para exprimir um gene
EA200600946A1 (ru) Способы продуцирования аполипопротеинов в трансгенных растениях
ES2073475T3 (es) Secuencias de dna utilizables en la sintesis de carotenoides.
HUP9900885A2 (hu) Hímsterilitás indukálása növényekben avidin nagy mennyiségben történő expresszálásával
HUP0002649A2 (hu) Hímsterilitás létrehozása növényekben, avidin magas szintű expresszáltatásával
HUP0500499A2 (hu) Eljárás növényekben a szervek tömegének megváltoztatására, a termékenység ellenőrzésére és az aszexuális reprodukció fokozására
DE502004000547D1 (de) Verfahren zur fermentativen Herstellung von L-Methionin
DE69636899D1 (de) Wirtszelle, die reduzierte mengen einer metalloprotease exprimiert und methoden zur verwendung dieser wirtszelle zur proteinproduktion
DK0506789T3 (da) Kloningsvektor til anvendelse i mælkesyrebakterier og fremgangsmåde til fremstilling af samme
AU2637099A (en) High efficiency methods and compositions for integrating exogenous dna into genomic dna of sperm
Ferrero et al. Human leukaemic cell lines
Kaufman et al. X chromosome inactivation in diploid parthenogenetic mouse embryos
Lelievre et al. Contact inhibition-plasma membranes enzymatic activities in cultured cell lines
IT202100023468A1 (it) Trasfezione di protoplasti di piante di vite con il complesso Cas9/gRNA e rigenerazione di relative piante di vite editate
AUPS333902A0 (en) Method of producing plants having enhanced transpiration efficiency and plants produced therefrom i
AR027762A1 (es) Acidos nucleicos aislados de plasmido pmr2 de micromonospora rosaria y vectores preparados a partir de los mismos
Samuelson et al. Cytological localization of adenosine kinase, nucleoside phosphorylase-1, and esterase-10 genes on mouse chromosome 14
Swale et al. Morphological observations on wild and cultured material of Rhodochorton investiens (Lenormand) nov. comb.(Balbiania investiens (Lenorm.) Sirodot)
MX2023011211A (es) Mosaicismo inducible.
ES8604645A1 (es) Un metodo de obtencion de celulas huesped de streptomycetes con actividad de restriccion reducida.
Jordan ‘2 S’RNA, A new ribosomal RNA component in cultured Drosophila cells

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010301